OpenEvidence Integrates FDA-Cleared AI for Heart Disease Detection
OpenEvidence has announced the integration of FDA-cleared artificial intelligence technology to assist in detecting heart disease.
The AI system is designed to help healthcare providers identify signs of heart disease earlier and more accurately. FDA clearance indicates the technology has met regulatory standards for safety and effectiveness in clinical settings.
This development represents a growing trend of AI tools being adopted in healthcare diagnostics, with heart disease detection being one of the most impactful applications given its status as a leading cause of death globally.